Lasa Supergenerics Limited

₹4.44As of Sun 8 Nov 2026, 12:00 UTC
NSE:LASAHealthcare
Country India
PE (Fwd) •••
TSR 9Y CAGR (30.87%)
Div yield 5.63%
ROE (51.13%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.68
PE TTM —
TSR TTM (61.72%)
Mkt cap ₹222.4M
ROIC (23.95%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹4.74
6.77%
(71.46%)
Hold 12|12|6|9|10
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
0.06
0.06
0.06
0.06
20.57%
7.65%
(0.09%)
(8.52%)
Revenue₹M
16.60
16.56
16.21
16.78
20.08%
13.25%
6.19%
3.90%
Peers (US$2.369M)
Cap (US$)
PE
4.954M
—
Capital
TTM
5Y
10Y
Leveragex
0.486
—
—
EBIT/Intx
0.941
0.042
0.040
Own earn%
72.42
126.07
120.23
Sh yield%
12.78
35.94
30.43
Owners
Insiders/Inst%
11.02
54.70
Short interest%
0.64
SBC / revenue%
2.70
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
21–29
$1 testx
0.0
Incr. ROIC%
17